10-K Decoder · All companies

Arrowhead Pharmaceuticals, Inc.

ARWR · FY2025 · Fiscal year ended Sep 30, 2025 · 10-K filed Nov 2025

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$829M$3.55M+23,265%
Operating income$98.3M−$601M
Net income−$1.63M−$599M+99.7%

Latest quarter: Q4 FY2026

Form 10-K · Three months ended Sep 30, 2026 (fourth quarter, from the 10-K) · filed Nov 12, 2026

$Q4 FY2026Year earlierChange
Revenue$37.8M$256M−85.3%
Operating income−$437M$44.1M
Net income−$428M−$23.8M−1,698%

Q4 FY2026 dashboardQ4 FY2026 infographic

Questions

What was Arrowhead's revenue in FY2025?
$829M in FY2025 (Fiscal year ended Sep 30, 2025), +23,265% vs $3.55M a year earlier, per its 10-K filed Nov 2025.
Was Arrowhead profitable in FY2025?
No: net income was −$1.63M and operating income $98.3M in FY2025.
What was Arrowhead's revenue in Q4 FY2026?
$37.8M (−85.3% vs a year earlier), per its Form 10-K filed Nov 12, 2026.